Psychiatry Flashcards
Methylphenidate (MOA)
CNS stimulant. Increases catecholamines at the synaptic cleft, especially norepi and dopamine
Methylphenidate (CU)
ADHD, narcolepsy, appetite control
Dextroamphetamine (MOA)
CNS stimulant. increases catecholamines at the synaptic cleft, especially norepi and dopamine
Dextroamphetamine (CU)
ADHD, narcolepsy, appetite control
Methamphetamine (MOA)
CNS stimulant. increases catecholamines at the synaptic cleft, especially norepi and dopamine
Methamphetamine (CU)
ADHD, narcolepsy, appetite control
Phentermine (MOA)
CNS stimulant. increases catecholamines at the synaptic cleft, especially norepi and dopamine
Phentermine (CU)
ADHD, narcolepsy, appetite control
Haloperidol
Typical antipsychotic (neuroleptic). Block dopamine D2 receptors -> Increase cAMP. High potency.
Schizophrenia (primarily positive symptoms), psychosis, acute mania, Tourette syndrome.
(T) Neurologic side effects. EPS symptoms. Neuroleptic malignant syndrome (NMS). Tardive dyskinesia.
Antipsychotics (neuroleptics) (T)
Highly lipid soluble and stored in body fat; thus very slow to be removed from body.
Extrapyramidal system effects (dyskinesias). treatment = benztropine or diphenhydramine
Endocrine side effects (dopamine receptor antagonism-> hyperprolactin-> galactorrhea)
Side effects from blocking muscarinic (dry mouth, constipation), a1 (hypotension), and histamine (sedation) receptors.
Neuroleptic malignant syndrome (NMS)
Rigidity, myoglobinuria, autonomic instability, hyperpyrexia. Treatment: dantrolene, D2 agonists (bromocriptine).
Toxicity associated with neuroleptic antipsychotics
Seen with haloperidol.
Tardive Dyskinesia
Stereotypic oral-facial movements as a result of long-term antipsychotic use. Potentially irreversible.
Toxicity associated with neuroleptic antipsychotics
Seen with haloperidol.
Trifluoperazine
Typical antipsychotic (neuroleptic). Block dopamine D2 receptors -> Increase cAMP. High potency.
Schizophrenia (primarily positive symptoms), psychosis, acute mania, Tourette syndrome.
Neurologic side effects (EPS symptoms)
Fluphenazine
Typical antipsychotic (neuroleptic). Block dopamine D2 receptors -> Increase cAMP. High potency.
Schizophrenia (primarily positive symptoms), psychosis, acute mania, Tourette syndrome.
Neurologic side effects (EPS symptoms)
Thioridazine
Typical antipsychotic (neuroleptic). Block dopamine D2 receptors -> Increase cAMP. Low potency.
Schizophrenia (primarily positive symptoms), psychosis, acute mania, Tourette syndrome.
Non-neuro side effects (anticholinergic, antihistaminic, and a1 blockade effects). Retinal deposits.
Chlorpromazine
Typical antipsychotic (neuroleptic). Block dopamine D2 receptors -> Increase cAMP. Low potency.
Schizophrenia (primarily positive symptoms), psychosis, acute mania, Tourette syndrome.
Non-neuro side effects (anticholinergic, antihistaminic, and a1 blockade effects). Corneal deposits.
For NMS think FEVER
Fever Encephalopathy Vitals unstable Enzymes elevated Rigidity of muscles
Olanzapine (MOA)
Atypical antipsychotic. Varied effect on 5-HT2, dopamine, and a- and H1-receptors.
Olanzapine (CU)
Schizophrenia - both positive and negative symptoms. Also used for bipolar disorder, OCD, anxiety disorder, depression, mania, Tourette syndrome.